Perioperative Prospective Follow Up Of Cannabis Consumers and Discrepancy Use
Condition(s) studied
Investigational drug(s) / intervention(s)
This study is non interventional and will only include filling in questionnaires and providing blood and urine sample: urine sample
Study summary
This study includes a prospective non interventional study that aims to asses the prevalence of cannabis use among patients undergoing elective surgery and evaluates its impact on perioperative outcomes, including pain, opioid consumption, nausea, anxiety, and sleep disturbances. A matched control cohort will provide comparative data. Discrepancies between self-reported and objectively measured cannabis use will be assessed using blood samples and urine samples. Participants will be requested to complete preoperative and postoperative questionnaires on days 1, 2, 3, 7, and 30 to monitor cannabis use and perioperative symptoms. This study aims to clarify the perioperative effects of cannabis use and the accuracy of patient-reported consumption.
Eligibility
Primary outcome measure(s)
- discrepancy percentage between reported cannabis users and actual cannabis usage among patients undergoing elective surgery. — up to 7 days
- Use of Cannabis — up to 7 days postopertively
Doasge Use of Cannabis
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hadassah Medical Center | Jerusalem | Israel |
More Hadassah Medical Organization trials in Israel
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07582445 on ClinicalTrials.gov ↗ ← All trials in Israel